Sana Biotechnology, Inc.
SANA
$4.09
$0.123.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.88% | -26.86% | -18.61% | -12.63% | 0.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.91% | -30.33% | -39.23% | -16.96% | -5.36% |
| Operating Income | 35.91% | 30.33% | 39.23% | 16.96% | 5.36% |
| Income Before Tax | 23.35% | -2.97% | 32.38% | 5.82% | -10.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 23.35% | -2.97% | 32.38% | 5.82% | -10.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.35% | -2.97% | 32.38% | 5.82% | -10.97% |
| EBIT | 35.91% | 30.33% | 39.23% | 16.96% | 5.36% |
| EBITDA | 37.08% | 31.38% | 40.75% | 17.26% | 5.16% |
| EPS Basic | 31.16% | 7.58% | 42.12% | 19.95% | 2.01% |
| Normalized Basic EPS | 44.23% | 39.67% | 48.57% | 29.88% | 15.93% |
| EPS Diluted | 31.14% | 7.57% | 42.11% | 19.94% | 2.02% |
| Normalized Diluted EPS | 44.23% | 39.45% | 48.42% | 29.67% | 15.67% |
| Average Basic Shares Outstanding | 9.99% | 12.02% | 17.36% | 18.68% | 14.69% |
| Average Diluted Shares Outstanding | 9.99% | 11.56% | 16.85% | 18.15% | 14.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |